Browse CATs

Browse CATs  internal medicine  endocrine and metabolic disorders  hyperkalaemia

Diagnosis Harm/ aetiology Prognosis Therapy

Hyperkalaemia bicarbonate potentiated the potassium-lowering effect of insulin and glucose. Level of evidence 2b Expiry Date February 2004 Hyperkalaemia calcium resin may decrease potassium levels. Level of evidence 4 Expiry Date April 2004 Hyperkalaemia isotonic bicarbonate lowered plasma potassium in haemodialysis patients. Level of evidence 2b Expiry Date February 2004 Hyperkalaemia isotonic bicarbonate infusions offered no real benefit in lowering potassium. Level of evidence 3b Expiry Date February 2004 Hyperkalaemia isotonic bicarbonate lowered plasma potassium in haemodialysis patients. Level of evidence 2b Expiry Date February 2004 Hyperkalaemia nebulized albuterol lowered potassium dialysis patients Level of evidence 4 Expiry Date October 2003 Hyperkalaemia albuterol and insulin together lowered potassium more than either alone in haemodialysis patients Level of evidence 4 Expiry Date October 2003